ArticleFrontiers in public health2019
Caseload and Case Fatality of Lassa Fever in Nigeria, 2001-2018: A Specialist Center's Experience and Its Implications.
Erratum issuedOpen access · goldAbstract read
In one paragraph
Article in Frontiers in public health, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 33 papers, 2 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 2 pooled it
4.2field-weighted citation impact, top 5% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
33 citing papers in PubMed, 2 syntheses or guidelines pooled it, 61 citations in OpenAlex.
- Clinical Outcomes of Severe Lassa Fever in West Africa: A Systematic Review and Meta-Analysis.International journal of environmental research and public health · 2025Pooled it
- Lassa fever in West Africa: a systematic review and meta-analysis of attack rates, case fatality rates and risk factors.BMC public health · 2025Pooled it
- Safety and Pharmacokinetics of LHF-535, a Potential Treatment for Lassa Fever, in Healthy Adults.Antimicrobial agents and chemotherapy · 2022Trial
- Lassa fever in the shadow of pregnancy - a case-control study of clinical presentation, risk factors and outcomes in Southern Nigeria.BMC pregnancy and childbirth · 2026Article
- Predictors of Acute Kidney Injury and In-Hospital Mortality in Patients With RT-PCR Confirmed Lassa Fever in Southwest Nigeria.Open forum infectious diseases · 2026Article
- Presence of Lassa Virus RNA in Cerebrospinal Fluid Indicating Neuroinvasive Lassa Fever in Pediatric Patients From Edo State, Nigeria.The Journal of infectious diseases · 2026Article
- The Biological Characteristics and Mouse Model of Lassa Virus From the First Imported Case in China.MedComm · 2025Article
- Knowledge and attitude of nosocomial infection prevention and control precautions among healthcare personnel at Kiruddu Referral Hospital in Kampala, Uganda.BMC health services research · 2025Article
- Virus Load Kinetics in Lassa Fever Patients Treated With Ribavirin: A Retrospective Cohort Study From Southern Nigeria.Open forum infectious diseases · 2024Article
- Lassa Fever: Critical Review and Prospects for Control.Tropical medicine and infectious disease · 2024Review
- Addressing bottlenecks in Lassa fever treatment: overcoming the ribavirin parenteral formulation challenge.Tropical medicine and health · 2024Article
- Knowledge and practices associated with Lassa fever in rural Nigeria: Implications for prevention and control.Journal of public health in Africa · 2023Article
- A human monoclonal antibody combination rescues nonhuman primates from advanced disease caused by the major lineages of Lassa virus.Proceedings of the National Academy of Sciences of the United States of America · 2023Article
- Structural conservation of Lassa virus glycoproteins and recognition by neutralizing antibodies.Cell reports · 2023Article
- Seroepidemiology of Lassa virus in pregnant women in Southern Nigeria: A prospective hospital-based cohort study.PLoS neglected tropical diseases · 2023Article
- Predictors of Lassa fever diagnosis in suspected cases reporting to health facilities in Nigeria.Scientific reports · 2023Article
- Transplacental transfer of Lassa IgG antibodies in pregnant women in Southern Nigeria: A prospective hospital-based cohort study.PLoS neglected tropical diseases · 2023Article
- An Outbred Guinea Pig Disease Model for Lassa Fever Using a Host-Adapted Clade III Nigerian Lassa Virus.Viruses · 2023Article
- Pharmacokinetics of Ribavirin in the Treatment of Lassa Fever: An Observational Clinical Study at the Irrua Specialist Teaching Hospital, Edo State, Nigeria.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023Observational
- The West Africa Lassa fever Consortium pre-positioned protocol for a Phase II/III adaptive, randomised, controlled, platform trial to evaluate multiple Lassa fever therapeutics.Wellcome open research · 2023Article
Corrections and comments
- Erratum issued
Authors and funding
27 authors at 7 institutions in 3 countries.
George O AkpedeInstitute of Lassa Fever Research and Control, Irrua Specialist Teaching Hospital, Irrua, Nigeria.
Danny A AsogunInstitute of Lassa Fever Research and Control, Irrua Specialist Teaching Hospital, Irrua, Nigeria.
Sylvanus A OkogbeninInstitute of Lassa Fever Research and Control, Irrua Specialist Teaching Hospital, Irrua, Nigeria.
Simeon O DawoduDepartment of Paediatrics, Irrua Specialist Teaching Hospital, Irrua, Nigeria.
Mojeed O MomohDepartment of Obstetrics and Gynaecology, Irrua Specialist Teaching Hospital, Irrua, Nigeria.
Andrew E DongoDepartment of Surgery, Irrua Specialist Teaching Hospital, Irrua, Nigeria.
Chiedozie IkeDepartment of Community Medicine, Irrua Specialist Teaching Hospital, Irrua, Nigeria.
Ekaete TobinInstitute of Lassa Fever Research and Control, Irrua Specialist Teaching Hospital, Irrua, Nigeria.
Nosa AkpedeInstitute of Lassa Fever Research and Control, Irrua Specialist Teaching Hospital, Irrua, Nigeria.
Ephraim Ogbaini-EmovonInstitute of Lassa Fever Research and Control, Irrua Specialist Teaching Hospital, Irrua, Nigeria.
Adetunji E AdewaleDepartment of Paediatrics, Irrua Specialist Teaching Hospital, Irrua, Nigeria.
Oboratare OcheiDepartment of Community Medicine, Irrua Specialist Teaching Hospital, Irrua, Nigeria.
Frank OnyekeDepartment of Paediatrics, Irrua Specialist Teaching Hospital, Irrua, Nigeria.
Martha O OkonofuaDepartment of Nursing Services, Irrua Specialist Teaching Hospital, Irrua, Nigeria.
Rebecca O AtafoInstitute of Lassa Fever Research and Control, Irrua Specialist Teaching Hospital, Irrua, Nigeria.
Ikponmwosa OdiaInstitute of Lassa Fever Research and Control, Irrua Specialist Teaching Hospital, Irrua, Nigeria.
Donatus I AdomehInstitute of Lassa Fever Research and Control, Irrua Specialist Teaching Hospital, Irrua, Nigeria.
George OdigieInstitute of Lassa Fever Research and Control, Irrua Specialist Teaching Hospital, Irrua, Nigeria.
Caroline OgbeifunDepartment of Medical Records, Irrua Specialist Teaching Hospital, Irrua, Nigeria.
Ekene MuebonamInstitute of Lassa Fever Research and Control, Irrua Specialist Teaching Hospital, Irrua, Nigeria.
Chikwe IhekweazuNigeria Centre for Disease Control, Abuja, Nigeria.
Michael RamharterDepartment of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine & I. Department of Medicine University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Andres ColubriDepartment of Organismic and Evolutionary Biology, Harvard University, Cambridge, MA, United States.
Pardis C SarbetiDepartment of Organismic and Evolutionary Biology, Harvard University, Cambridge, MA, United States.
Christian T HappiDepartment of Biological Sciences and African Center of Excellence for Genomics of Infectious Diseases, Redeemer's University, Ede, Nigeria.
Stephan GüntherDepartment of Virology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
Dennis E AgbonlahorDepartment of Microbiology, Ambrose Alli University, Ekpoma, Nigeria.
Irrua Specialist Teaching Hospital · NGHarvard University · USAmbrose Alli University · NGBernhard Nocht Institute for Tropical Medicine · DENigeria Centre for Disease Control · NGRedeemer's University · NGUniversität Hamburg · DE
Funding
Viral Genomics: evolution, spread, and host interactionsU19AI110818 · NIAID · BROAD INSTITUTE, INC. · PI EARL, ASHLEE MIRIAM · 2014 to 2024
$66.5MUtilize Microbial Metagenomics for Viral Pathogen CharacterizationU54HG007480 · NHGRI · REDEEMER'S UNIVERSITY · PI HAPPI, CHRISTIAN T. · 2017 to 2022
$5.5MElucidating Genetic Determinants of Resistance to Lassa Hemorrhagic FeverR01AI114855 · NIAID · BROAD INSTITUTE, INC. · PI SABETI, PARDIS CHRISTINE · 2015 to 2019
$3.8MHost and Microbial Genetic Determinants of Febrile Illness in West AfricaU01HG007480 · NHGRI · REDEEMER'S UNIVERSITY · PI HAPPI, CHRISTIAN T. · 2013 to 2016
$1.6MNHGRI NIH HHS U01 HG007480NHGRI NIH HHS U54 HG007480NIAID NIH HHS R01 AI114855NIAID NIH HHS U19 AI110818
Abstract
PubMed holds no abstract for this paper.
Indexed as
case fatalitycaseloadcenter's experienceimplicationsLassa feverNigeriaoutbreakstrends
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.